CD274 and lung carcinoma: However, it reinforces that PD‐L1 expression in lung cancer could be heterogeneous and dynamic, hence the reliability and feasibility of the PD‐L1 expression on a single biopsy specimen, as a reference for immuno‐oncology treatment, remains controversial.53, 54